Highline Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Highline Wealth Partners's LLY Position: Q3 2026 in Review
Highline Wealth Partners increased its Eli Lilly (LLY) stake by 58% in Q3 2026, buying an estimated $123K and bringing the position to 284 shares worth $329K. The position accounts for 0.06% of the portfolio, ranked #90.
Highline Wealth Partners first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. 1,387 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Highline Wealth Partners held 284 shares of Eli Lilly worth $329K as of Q3 2026.
- Highline Wealth Partners bought 104 Eli Lilly shares in Q3 2026, an estimated $123K.
- Eli Lilly made up 0.06% of Highline Wealth Partners's portfolio in Q3 2026, its #90 holding.
- Highline Wealth Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- 1,387 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.